750 Preclinical characteristics of ITMN-B, an orally active inhibitor of the HCV NS3/4A protease nominated for preclinical development
- 30 April 2006
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 44, S278
- https://doi.org/10.1016/s0168-8278(06)80751-8
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: